PRKDC and cancer: Hence, reducing MYC activity limits the cell’s ability to cope with replication stress, and when this is coupled with inhibition of key DNA repair pathways such as ATR/CHK1, WEE1, DNA-PKcs, or PARP, cancer cells can be pushed toward irreversible genomic instability.